Innovative Medical Management Stock Annual Yield
| 002173 Stock | 11.83 0.61 4.90% |
Innovative Medical Management fundamentals help investors to digest information that contributes to Innovative Medical's financial success or failures. It also enables traders to predict the movement of Innovative Stock. The fundamental analysis module provides a way to measure Innovative Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Innovative Medical stock.
Innovative | Annual Yield |
Innovative Medical Management Company Annual Yield Analysis
Innovative Medical's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Innovative Medical Management has an Annual Yield of 0.0%. This indicator is about the same for the Health Care Providers & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all China stocks average (which is currently at 0.0).
Innovative Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Innovative Medical's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Innovative Medical could also be used in its relative valuation, which is a method of valuing Innovative Medical by comparing valuation metrics of similar companies.Innovative Medical is currently under evaluation in annual yield category among its peers.
Innovative Fundamentals
| Return On Equity | -0.0256 | ||||
| Return On Asset | -0.0147 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0.08) % | ||||
| Current Valuation | 4.74 B | ||||
| Shares Outstanding | 441.28 M | ||||
| Shares Owned By Insiders | 40.78 % | ||||
| Shares Owned By Institutions | 1.64 % | ||||
| Price To Book | 2.83 X | ||||
| Price To Sales | 6.45 X | ||||
| Revenue | 805.59 M | ||||
| Gross Profit | 74.08 M | ||||
| EBITDA | 33.94 M | ||||
| Net Income | (34.29 M) | ||||
| Total Debt | 30.17 M | ||||
| Book Value Per Share | 4.17 X | ||||
| Cash Flow From Operations | 11.03 M | ||||
| Earnings Per Share | (0.11) X | ||||
| Beta | 0.62 | ||||
| Market Capitalization | 5.22 B | ||||
| Total Asset | 2.28 B | ||||
| Retained Earnings | (1.3 B) | ||||
| Working Capital | 407.63 M | ||||
| Net Asset | 2.28 B |
About Innovative Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Innovative Medical Management's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovative Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovative Medical Management based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Innovative Stock
Innovative Medical financial ratios help investors to determine whether Innovative Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Innovative with respect to the benefits of owning Innovative Medical security.